Biphenyl oxadiazinone angiotensin II inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544 68, A61K 31535, C07D27304

Patent

active

052254089

ABSTRACT:
Angiotension II inhibition is exhibited by ##STR1## wherein: R.sup.1 and R.sup.2 are each independently hydrogen, alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, thiophenalkyl, pyridylalkyl, or --R.sup.8 CO.sub.2 R.sup.9 ;

REFERENCES:
patent: 4508718 (1985-04-01), Sircar et al.
patent: 4812462 (1989-03-01), Blankley et al.
patent: 4820843 (1989-04-01), Aldrich et al.
patent: 4870186 (1989-09-01), Aldrich et al.
patent: 4874867 (1989-10-01), Aldrich et al.
patent: 4880804 (1989-11-01), Carini et al.
patent: 5064825 (1991-11-01), Chakravarty et al.
Chiu et al., European Journal of Pharmacology, 157 (1988) pp. 13-21.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Biphenyl oxadiazinone angiotensin II inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biphenyl oxadiazinone angiotensin II inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biphenyl oxadiazinone angiotensin II inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1689695

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.